Home › Funds › D. E. Shaw & Co., Inc. › CAI

D. E. Shaw & Co., Inc. position in CAI

CARIS LIFE SCIENCES INC · Health Care

D. E. Shaw & Co., Inc. reported holding 7,218,295 shares of CAI (CARIS LIFE SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$221.1M, representing 0.31% of its reported portfolio and ranking #49 among its reported holdings. D. E. Shaw & Co., Inc. has disclosed CAI holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)7.22M sh
Reported value held$221.10M
Portfolio Weight0.31%
First reportedQ2 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How D. E. Shaw & Co., Inc.'s CAI position evolved

D. E. Shaw & Co., Inc. first disclosed a stake in CAI in Q2 2025 at 7,500 shares (US$200K). The position peaked in Q3 2026 at 7,218,295 shares, worth US$221.1M. Across 5 filings, D. E. Shaw & Co., Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 7,218,295 shares valued at US$221.1M — an increase of 7,013,477 shares quarter over quarter.. Notable position changes include a 564% increase in Q3 2025 (shares fell 11% over the following quarter), a 58% increase in Q2 2026 (shares rose 72% over the following quarter), a 3424% increase in Q3 2026 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 7.50K $200.40K New
Q3 2025 49.78K $1.51M Add
Q1 2026 129.58K $2.32M New
Q2 2026 204.82K $3.65M Add
Q3 2026 7.22M $221.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAI and 13F data

CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 66 other funds we track also report a position in CAI — the largest reported positions include Coatue Management (US$175.0M), Sixth Street Partners Management Company, L.P. (US$92.9M), BRAIDWELL LP (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAI

All CAI fund holders →

FAQ

How long has D. E. Shaw & Co., Inc. held CAI?

D. E. Shaw & Co., Inc. has disclosed CAI holdings in 5 of the last 6 reported quarters, going back to Q2 2025.

What is D. E. Shaw & Co., Inc.'s current position in CAI?

As of Q3 2026, D. E. Shaw & Co., Inc. holds 7.22M shares of CAI (CARIS LIFE SCIENCES INC), valued at $221.10M, representing 0.31% of its reported portfolio and ranking #49.

Has D. E. Shaw & Co., Inc. been buying or selling CAI?

In the latest 13F filing (Q3 2026), D. E. Shaw & Co., Inc. increased its position in CAI. The position peaked in Q3 2026 at 7.22M shares.

Which other funds hold CAI?

Other major institutional holders of CAI include Coatue Management, Sixth Street Partners Management Company, L.P., BRAIDWELL LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.